KPVSupplier ComparisonGut Health

Best KPV Suppliers in 2026: 48 Vendors, Real Prices

We priced KPV across all 48 vendors we track. The same 10 mg vial runs $33.00 to $79.99, median $5.50 per mg, and the highest-scored seller on our board charges $4.30. Here are the sellers we would shop.

PeptidesRated·September 10, 2026·7 min read
Best KPV Suppliers in 2026: 48 Vendors, Real Prices: PeptidesRated guide hero image

Peptidology sells a 10 mg vial of KPV for $42.99. That works out to $4.30 per mg, and the median across the 48 vendors we track is $5.50 per mg. So the shop sitting at the very top of our vendor board, PR Score 9.3 out of 10, first of 74, is also asking about 20 percent under the middle of the market on this compound. Reputation usually costs extra. On KPV the two happen to line up, which makes this an unusually easy peptide to shop for.

Three amino acids, forty-eight sellers

KPV is lysine, proline, valine. Three residues, 342.43 g/mol, catalogued on PubChem as MSH (11-13) because it is the tail end of alpha-melanocyte-stimulating hormone, residues 11 through 13. That makes it one of the two smallest molecules we track, alongside GHK-Cu, which is also a tripeptide. BPC-157 runs 15 amino acids. IGF-1 LR3 runs 83.

You would expect that size difference to show up hard in the price. It barely does. KPV's median lands at $5.50 per mg across 48 vendors; BPC-157 sits at $6.00 per mg across 61. A molecule a fifth the length holds 92 percent of the price. Synthesis stopped being the cost driver a while ago. What you are paying for is vialing, third-party testing, and the seller's margin.

Forty-eight vendors is a crowded shelf for a compound that was obscure two years ago. For scale, our tirzepatide page lists 21 vendors and semaglutide lists 19. KPV outdraws both GLP-1s combined, which tells you where the gut-health interest went.

What the research actually covers

The property that made KPV interesting: it keeps the anti-inflammatory behavior of the parent hormone and drops the pigmentary activity. Melanotan II, the other alpha-MSH derivative in our catalog, goes the other direction entirely.

Two 2008 papers carry most of the weight.

Kannengiesser and colleagues, Inflammatory Bowel Diseases, March 2008 (14(3):324-331). In DSS colitis and transfer colitis mouse models, KPV-treated animals recovered earlier and regained body weight, with reduced inflammatory infiltrate on histology and lower colonic MPO activity. The effect held in mice lacking a functional MC1R, so the mechanism appears at least partly receptor independent.
Dalmasso and colleagues, Gastroenterology, January 2008 (134(1):166-178). KPV enters colonic epithelial and immune cells through PepT1, the di- and tripeptide transporter that gets upregulated in the inflamed colon. Orally administered KPV lowered colitis severity and pro-inflammatory cytokine expression in DSS and TNBS models.

That PepT1 route is why oral capsules and nasal sprays turn up on KPV product pages at all. Our data lists injection, nasal, oral and pen formats for this one, and most peptides we track are injection-only. If you are mapping the wider category, our peptides for gut health piece works through BPC-157 and larazotide, the two compounds with the deepest GI research behind them.

Scope note we will state plainly: this is 2008 rodent and cell work. Human trial data on KPV is thin, and everything on the market is sold for research purposes.

The FDA spent a day on KPV in July

On July 23, 2026, the Pharmacy Compounding Advisory Committee reviewed KPV free base and KPV acetate under the heading "wound healing and inflammatory conditions" as part of the 503A Bulks List process. The committee backed KPV alongside BPC-157, TB-500, MOTS-c, Epitalon and Semax. Those votes are advisory, and FDA and HHS still have to act on them, so the compound remains research-only for now. We walked through the wider vote in our FDA peptide reclassification piece.

One detail from that docket is worth carrying into your COA reading: the agency lists free base and acetate as separate substances. Salt form changes how much actual KPV is in the vial.

The 10 mg vial is the unit to compare

Thirty-five of the 48 vendors sell a 10 mg vial, which makes this one of the cleaner peptides to price-shop. Twelve offer 5 mg, a handful offer 2 and 4 mg, and a few list multi-vial kits at 50 and 100 mg.

Among vendors with that 10 mg vial in stock today, the price runs from $33.00 to $79.99. Same molecule, same quantity, 2.4x spread. The in-stock median works out to roughly $5.06 per mg.

Bulk kits go lower. Pure Health Peptides lists a 40 mg option at $129, or $3.23 per mg, the cheapest verified KPV on our board.

Where we would buy KPV right now

All 48 vendors publish a third-party COA, which is unusual and genuinely good news. That means the sorting comes down to which lab did the work, whether the vial is actually in stock, and what you pay.

Top pick: Peptidology

PR Score 9.3 out of 10, ranked 1st of 74 vendors, and the highest-scoring seller on our entire board. Finnrick lab tier, based in Scottsdale, ships US, and takes ACH, card, crypto and Zelle. The 10 mg vial is $42.99, or $4.30 per mg, in stock. Best score plus a below-median price is a combination we rarely get to write. Full scorecard.

Value pick: Peptide Crafters

8.3 out of 10, 4th of 74, Finnrick tested, US based, 22 peptides tracked on PeptidesRated. The 10 mg vial runs $40.00, or $4.00 per mg. Card is the only payment method, which is the tradeoff for the price. Scorecard.

Runner-up on score: Orbitrex Peptides

9.0 out of 10, 2nd of 74, Finnrick tested, shipping from Flower Mound, Texas. The 10 mg vial is $49.99, or $5.00 per mg. If Peptidology is out of stock when you look, this is the next call. Scorecard.

Cheapest we are comfortable recommending: Panda Peptides

7.8 out of 10, 14th of 74, Janoshik tested, shipping to the US from the Greater Toronto Area. The 10 mg vial is $39.99, or $4.00 per mg, and this vendor has the widest payment set of anyone here: Apple Pay, Google Pay, CashApp, Zelle, bank transfer and card. Scorecard.

Also worth your shortlist

Atomik Labz (8.6, 3rd of 74, Finnrick, $55 for 10 mg), NuLife Peptides (8.3, 5th, Finnrick, $55), Peptide Technologies (8.1, 6th, Finnrick, $49.95) and SimplePeptide (8.0, 8th, Freedom Diagnostics, $45). Any of these clears the bar comfortably.

The full ranked list, sortable by price, lab and shipping, lives on our KPV vendor page. Every vendor on this site is scored the same way: how we score vendors.

What a strong KPV certificate of analysis shows

A tripeptide is easy to analyze, so the bar for a good COA here is higher than it is for a 60-residue protein.

The salt form, stated outright. Free base or acetate, ideally with net peptide content, so you know how many milligrams of KPV you actually hold.
HPLC purity with the chromatogram attached, so you can see the baseline and the side peaks yourself.
Mass spectrometry confirming 342.4 Da. On a molecule this small, mass confirmation is fast and cheap, and it is the single clearest proof that the vial holds what the label says.
A batch number that matches the vial in your hand, with a test date close to the manufacture date.
A lab you can independently look up. Finnrick, Janoshik and Freedom Diagnostics all publish results you can verify.

Our walkthrough of reading these documents line by line is at how to read a peptide COA, and the lab-by-lab detail is in Janoshik testing explained.

Prices here were pulled from our vendor pipeline on September 10, 2026 and refresh weekly. Vials sell out, and the ranking moves with them, so check the live vendor board before you buy.

Sources

Kannengiesser K, et al. "Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease." Inflammatory Bowel Diseases, 2008. https://pubmed.ncbi.nlm.nih.gov/18092346/

Dalmasso G, et al. "PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation." Gastroenterology, 2008. https://pubmed.ncbi.nlm.nih.gov/18061177/

FDA. "July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee." https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026

NCPA. "FDA advisory committee nominates six peptides for pharmacies to compound," July 31, 2026. https://ncpa.org/newsroom/qam/2026/07/31/fda-advisory-committee-nominates-six-peptides-pharmacies-compound

PubChem, National Library of Medicine. "Msh (11-13)," CID 125672, C16H30N4O4, 342.43 g/mol. https://pubchem.ncbi.nlm.nih.gov/compound/125672

PeptidesRated KPV vendor data, 48 verified vendors, September 10, 2026. https://peptidesrated.com/peptide/kpv

Continue exploring

Ready to find a supplier?

Compare providers on testing transparency, pricing, and COA access.

Peptide Roundup Weekly

New COA batches, supplier reviews, and peptide guides, delivered weekly.

Share

Disclaimer

This article is for informational and educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any peptide therapy.